Pyxis Oncology, Inc. (PYXS)
Pharmaceutical Preparations
Latest Price
$3.33
TTM P/E
--
Normalized P/E
1.23
Div Yield
--
Book Value
0.18
P/B Ratio
18.54
Institutional Ownership
54.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GordonMD Global Investments LP | 10.02M | $30.0M | 15.80% | +5.90M | 2026-06-30 |
| Pfizer Inc | 7.03M | $19.0M | 11.09% | -- | 2026-06-30 |
| Laurion Capital Management LP | 4.90M | $14.0M | 7.73% | -96.4K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.08M | $6.0M | 3.27% | +42.5K | 2026-06-30 |
| Atle Fund Management AB | 966.5K | $2.0M | 1.52% | +769.4K | 2026-06-30 |
| BlackRock, Inc. | 867.9K | $2.0M | 1.37% | +79.1K | 2026-06-30 |
| Palo Alto Investors LP | 864.3K | $2.0M | 1.36% | -146.2K | 2026-06-30 |
| MARSHALL WACE, LLP | 830.5K | $2.0M | 1.31% | +476.1K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 772.2K | $2.0M | 1.22% | -116.4K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 591.8K | $1.0M | 0.93% | -6.3K | 2026-06-30 |